Cervical Ripening for Induction of Labor

Abstract

Decrease in Cervidil use for cervical ripening by 20% of anticipated doses prior to Dec 1, 2018 (6 mos) , with a potential for cost savings = 40 doses x approx. 2000/dose=2000/dose = 80,000

    Similar works